Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MRNS
14201
CALL
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.02K | ﹤0.01% |
1,900
-32,600
| -94% | -$22.7K |
2020 Q4
16 quarters
|
|
14202
PUT
Oil States International
OIS
$496M
| $1.01K | ﹤0.01% |
200
-1,000
| -83% | -$4.98K |
2022 Q4
8 quarters
|
|
|
NEXN
14203
CALL
Nexxen International
NEXN
$502M
| $1K | ﹤0.01% |
100
-2,700
| -96% | -$23.9K |
2024 Q3
1 quarter
|
|
14204
Swvl Holdings Corp Warrant
SWVLW
$106K
| $990 | ﹤0.01% |
81,838
+3,336
| +4% | +$57 |
2024 Q3
1 quarter
|
|
|
LITS
14205
CALL
Lite Strategy Inc
LITS
$42M
| $984 | ﹤0.01% |
+400
| New | +$1.11K |
2024 Q4
0 quarters
|
|
|
BLFY
14206
PUT
DELISTED
Blue Foundry Bancorp
BLFY
| $981 | ﹤0.01% |
100
| – | – |
2024 Q3
1 quarter
|
|
|
BMTX
14207
PUT
DELISTED
BM Technologies, Inc.
BMTX
| $978 | ﹤0.01% |
+200
| New | +$870 |
2024 Q4
0 quarters
|
|
14208
PUT
Beyond Air
XAIR
$2.78M
| $968 | ﹤0.01% |
7
-2
| -22% | -$359 |
2021 Q1
15 quarters
|
|
|
CMBM
14209
PUT
DELISTED
Cambium Networks
CMBM
| $967 | ﹤0.01% |
1,500
-1,600
| -52% | -$1.88K |
2022 Q2
10 quarters
|
|
14210
SHF Holdings Warrants
SHFSW
$143K
| $967 | ﹤0.01% |
22,603
+100
| +0.4% | +$3 |
2024 Q1
3 quarters
|
|
14211
PUT
Outlook Therapeutics
OTLK
$144M
| $945 | ﹤0.01% |
+500
| New | +$2.06K |
2024 Q4
0 quarters
|
|
|
CALY
14212
Callaway Golf Company
CALY
$2.58B
| $943 | ﹤0.01% |
120
-1,929,446
| -100% | -$17.5M |
2019 Q1
23 quarters
|
|
|
BNIXW
14213
DELISTED
Bannix Acquisition Corp. Warrant
BNIXW
| $942 | ﹤0.01% |
33,873
+13,767
| +68% | +$295 |
2024 Q2
2 quarters
|
|
14214
PUT
Invivyd
IVVD
$242M
| $931 | ﹤0.01% |
2,100
| – | – |
2023 Q4
4 quarters
|
|
14215
Aclarion Warrant
ACONW
$60K
| $920 | ﹤0.01% |
39,996
+3,407
| +9% | +$103 |
2024 Q3
1 quarter
|
|
14216
PUT
Inogen
INGN
$158M
| $917 | ﹤0.01% |
100
-3,600
| -97% | -$33.7K |
2023 Q1
7 quarters
|
|
14217
PUT
Aveanna Healthcare
AVAH
$2.75B
| $914 | ﹤0.01% |
200
+100
| +100% | +$512 |
2024 Q1
3 quarters
|
|
14218
PUT
TELA Bio
TELA
$51.5M
| $906 | ﹤0.01% |
300
+200
| +200% | +$562 |
2024 Q1
3 quarters
|
|
|
ATXS
14219
CALL
DELISTED
Astria Therapeutics
ATXS
| $894 | ﹤0.01% |
100
-5,600
| -98% | -$59.5K |
2022 Q4
8 quarters
|
|
14220
PUT
SurgePays
SURG
$7.76M
| $890 | ﹤0.01% |
500
-23,200
| -98% | -$40.9K |
2022 Q4
8 quarters
|
|
14221
CALL
Outset Medical
OM
$74.4M
| $888 | ﹤0.01% |
53
-3,027
| -98% | -$37.8K |
2022 Q4
8 quarters
|
|
14222
Stem
STEM
$41M
| $886 | ﹤0.01% |
74
-1,205
| -94% | -$10.4K |
2024 Q3
1 quarter
|
|
|
BYNOW
14223
DELISTED
byNordic Acquisition Corporation Warrant
BYNOW
| $848 | ﹤0.01% |
24,232
+2,323
| +11% | +$101 |
2022 Q2
10 quarters
|
|
|
CKPT
14224
DELISTED
Checkpoint Therapeutics
CKPT
| $842 | ﹤0.01% |
263
-12,853
| -98% | -$43.6K |
2024 Q3
1 quarter
|
|
|
AREBW
14225
DELISTED
American Rebel Holdings Warrants
AREBW
| $821 | ﹤0.01% |
631
+9
| +1% | +$9 |
2023 Q4
4 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.